http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105237504-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105237504-B |
| titleOfInvention | Nitrogenous analog derivative of myricetin and its preparation method and application |
| abstract | The present invention relates to nitrogenous analog derivative of a kind of myricetin and its preparation method and application, compound structure has general formula (III) expression.Invention describes using myricetrin, halogenated alkane, secondary amine, piperazine hexahydrate, aromatic acid, substituted aroma acid, bromoacetate, hydrazine hydrate, aromatic aldehyde and substituted aroma aldehyde as raw material, be substituted, hydrolyze and condensation reaction synthesizes a series of nitrogenous analog derivatives of myricetin.Such compound has cancer cell good inhibiting effect, and toxicity is smaller, available for preparing anticancer drug. |
| priorityDate | 2014-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 176.